Alison Schram

27PUBLICATIONS
312CO-AUTHORS
Molecular targetsAutonomic nervous systemCancer cell biologyPredictive and prognostic markersProteins and peptides
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|Jul 01, 2026
Efficacy and Tolerability of Zenocutuzumab in Advanced <i>NRG1</i> Fusion-Positive Cholangiocarcinoma: Results From the eNRGy Phase II Trial.

|Mar 04, 2026
Beamion PANTUMOR-1: rationale and design of a Phase II trial of zongertinib in HER2-overexpressed/amplified or <i>HER2</i>-mutant solid tumors.

Alison M Schram, John J Park, Antoine Italiano

|Dec 22, 2025
CRESTONE: A Phase II Study of the Efficacy and Safety of the HER3 Monoclonal Antibody, Seribantumab, in Solid Tumors With Neuregulin-1 (<i>NRG1</i>) Fusions.

Tejas Patil, Jessica J Lin, Parneet K Cheema

|Dec 02, 2025
Reflections on Advances in Cancer Research in 2025.

Elsa Bernard, Isidro Cortés-Ciriano, Federico Gaiti

|Oct 07, 2025
The Bi-steric, mTORC1-Selective Inhibitor, RMC-5552, in Advanced Solid Tumors: A Phase 1 Trial.

Alison M Schram, Abdul Rafeh Naqash, Eric B Haura

|Sep 30, 2025
Tumor-Agnostic AKT Inhibition: Is It Time to AKT?

Ricardo Dahmer Tiecher, Alison M Schram

Pageof 5

Frequent Collaborators

9 joint publications

Alexander E Drilon

3 joint publications

Ahmet Zehir

3 joint publications

Misako Nagasaka

3 joint publications

Maurizio Scaltriti